Biogen (United States)
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Biogen (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
53%
Total
Publications
6.3K
Total Open
Publications
3.3K
Total
Citations
270K
Open Access
Percentage
53%
Total
Publications
6.3K
Total Open
Publications
3.3K
Total
Citations
270K
Breakdown
Publisher Open
18%
Both
25%
Other Platform Open
10%
Closed
47%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 27%
715
Hybrid 37%
987
No Guarantees 36%
953
Other Platform Open
Domain 80%
1.7K
Institution 28%
598
Other Internet 14%
301
Preprint 12%
257
Public 9%
185
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 1.7K |
Europe PMC | Domain | 1.2K |
DOI | Other Internet | 170 |
Semantic Scholar | Public | 146 |
bioRxiv | Preprint | 126 |
University College London - UCL Discovery | Institution | 117 |
Figshare | Public | 59 |
medRxiv | Preprint | 55 |
University of Cambridge - Apollo | Institution | 48 |
Research Square | Preprint | 41 |